N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide

C20H28ClN3O3 — CID 154871382

IUPACN-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide
SMILESNCCC1CCC(NC(=O)C(=O)N2C[C@@H](CO)[C@H](c3ccc(Cl)cc3)C2)C1
InChIInChI=1S/C20H28ClN3O3/c21-16-4-2-14(3-5-16)18-11-24(10-15(18)12-25)20(27)19(26)23-17-6-1-13(9-17)7-8-22/h2-5,13,15,17-18,25H,1,6-12,22H2,(H,23,26)/t13?,15-,17?,18-/m0/s1
InChIKeyDOUYHGRVADPPOL-NAIXVUCJSA-N
MW393.92 g/mol
LogP1.51
Rot. Bonds5

About N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide

N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide (PubChem CID 154871382) has the molecular formula C20H28ClN3O3 and a molecular weight of 393.92 g/mol. Its IUPAC name is N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide.

Molecular Properties

Compound NameN-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide
PubChem CID154871382
Molecular FormulaC20H28ClN3O3
Molecular Weight393.92 g/mol
Exact Mass393.18
IUPAC NameN-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide
SMILESNCCC1CCC(NC(=O)C(=O)N2C[C@@H](CO)[C@H](c3ccc(Cl)cc3)C2)C1
InChIInChI=1S/C20H28ClN3O3/c21-16-4-2-14(3-5-16)18-11-24(10-15(18)12-25)20(27)19(26)23-17-6-1-13(9-17)7-8-22/h2-5,13,15,17-18,25H,1,6-12,22H2,(H,23,26)/t13?,15-,17?,18-/m0/s1
InChIKeyDOUYHGRVADPPOL-NAIXVUCJSA-N
XLogP1.51
TPSA95.66 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500393.92
LogP ≤ 51.51
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide?
The IUPAC name of N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide (CID 154871382) is N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide.
What is the SMILES notation for N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide?
The canonical SMILES for N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide is NCCC1CCC(NC(=O)C(=O)N2C[C@@H](CO)[C@H](c3ccc(Cl)cc3)C2)C1.
What is the InChIKey of N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide?
The InChIKey is DOUYHGRVADPPOL-NAIXVUCJSA-N. The full InChI is InChI=1S/C20H28ClN3O3/c21-16-4-2-14(3-5-16)18-11-24(10-15(18)12-25)20(27)19(26)23-17-6-1-13(9-17)7-8-22/h2-5,13,15,17-18,25H,1,6-12,22H2,(H,23,26)/t13?,15-,17?,18-/m0/s1.
What are the key properties of N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide?
N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide has a molecular weight of 393.92 g/mol, XLogP of 1.51, 5 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(2-aminoethyl)cyclopentyl]-2-[(3R,4S)-3-(4-chlorophenyl)-4-(hydroxymethyl)pyrrolidin-1-yl]-2-oxoacetamide is sourced from PubChem (CID 154871382), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).